Nasal spray may treat Alzheimer’s, say scientists

Nasal spray may treat Alzheimer’s, say scientists

5:02 AM, 13th January 2015
Nasal spray may treat Alzheimer’s, say scientists
A nasal spray that contains a man-made form of insulin may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer’s, scientists have found.

WASHINGTON DC, US: A nasal spray that contains a man-made form of insulin may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer’s, scientists have found. The study led by researchers at Wake Forest Baptist Medical Center studied 60 adults diagnosed with amnesic mild cognitive impairment (MCI) or mild to moderate Alzheimer’s dementia (AD).

Researchers found that those who received nasally administered 40 international unit (IU) doses of insulin detemir, a manufactured form of the hormone, for 21 days showed significant improvement in their short-term ability to retain and process verbal and visual information compared with those who received 20 IU doses or a placebo.

Recipients of 40 IU doses carrying the APOE-e4 gene - known to increase the risk for Alzheimer’s - recorded significantly higher scores than those who received the lower dosage, while non-carriers across all three groups posted significantly lower scores. Previous trials had shown promising effects of nasally administered insulin for adults with AD and MCI, but this study was the first to use insulin detemir.

© TimesOfIndia News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Clariant acquires remaining shares of Companhia Brasileira de Bentonita

MUTTENZ, SWITZERLAND: Clariant, a world leader in specialty chemicals, signed an agreement to acquire the remaining 50 per cent shares of Companhia Br ...

Read more
Onex to acquire Survitec for $680 million

LONDON, UK: Onex Corporation has agreed to acquire Survitec Group Limited for $680 million (£450 million). The transaction is anticipated to clo ...

Read more
Beer digesting bacteria may fight against diseases, finds new study

NEWCASTLE, UK: A recent study led by Harry Gilbert, professor of biochemistry at Newcastle University, Eric Martens of the University of Michigan&rsqu ...

Read more
Shire to acquire NPS Pharmaceuticals for $5.2 billion

DUBLIN, IRELAND/BEDMINSTER, US: Shire plc and NPS Pharmaceuticals, Inc announced that the companies have entered into a merger agreement pursuant to w ...

Read more
Developing light-activated nanocarrier to transport proteins into cells

CALIFORNIA, US: University of California, Santa Barbara’s (UCSB) Reich Group uses lasers to spatially and temporally control the release of a ta ...

Read more
AMRI to acquire Aptuit’s drug product development and aseptic clinical manufacturing businesses

ALBANY, US: Albany Molecular Research Inc (AMRI) has acquired the outstanding equity interests of Aptuit’s Glasgow, UK business and has entered ...

Read more